Cargando…

Biosimilar insulins: An unavoidable option in South-East Asia

Detalles Bibliográficos
Autor principal: Kaduskar, Prashant Ulhas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911853/
https://www.ncbi.nlm.nih.gov/pubmed/27366730
http://dx.doi.org/10.4103/2230-8210.183462
_version_ 1782438184945188864
author Kaduskar, Prashant Ulhas
author_facet Kaduskar, Prashant Ulhas
author_sort Kaduskar, Prashant Ulhas
collection PubMed
description
format Online
Article
Text
id pubmed-4911853
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49118532016-07-01 Biosimilar insulins: An unavoidable option in South-East Asia Kaduskar, Prashant Ulhas Indian J Endocrinol Metab Letters to the Editor Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4911853/ /pubmed/27366730 http://dx.doi.org/10.4103/2230-8210.183462 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Letters to the Editor
Kaduskar, Prashant Ulhas
Biosimilar insulins: An unavoidable option in South-East Asia
title Biosimilar insulins: An unavoidable option in South-East Asia
title_full Biosimilar insulins: An unavoidable option in South-East Asia
title_fullStr Biosimilar insulins: An unavoidable option in South-East Asia
title_full_unstemmed Biosimilar insulins: An unavoidable option in South-East Asia
title_short Biosimilar insulins: An unavoidable option in South-East Asia
title_sort biosimilar insulins: an unavoidable option in south-east asia
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911853/
https://www.ncbi.nlm.nih.gov/pubmed/27366730
http://dx.doi.org/10.4103/2230-8210.183462
work_keys_str_mv AT kaduskarprashantulhas biosimilarinsulinsanunavoidableoptioninsoutheastasia